About this trial
"Assessment of postoperative pain with conventional and tumescent local anesthesia in the laser treatment of pilonidal sinus."
The aim of this study is to:
examine the possible difference in postoperative pain between two local anesthesia procedures after laser treatment of pilonidal sinus disease on the first and second postoperative day, as well as one week after surgery.
During the procedure, two well-established anesthesia techniques are used to make the surgical area painless.
The first is local anesthesia, in which the anesthetic is injected into and under the skin.
The second procedure is tumescent anesthesia. In this procedure, the anesthetic in diluted form is introduced into the subcutaneous tissue. Both procedures are used in surgery and are standard methods of local anesthesia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed pilonidal sinus disease
Laser treatment for pilonidal sinus disease
Able to provide informed consent
Disqualifiers
Recurrent pilonidal sinus
Chronic pain syndrome
Prisoners
Trial design
Parallel
Treatments tested in this trial
local anesthesia using 2% lidocaine
DrugIntervention Type: Drug Intervention Name: Lidocaine 2% Description: Conventional local anesthesia using 2% lidocaine infiltrated into the operative field prior to SiLaC.
SiLaC
DeviceIntervention Type: Device Intervention Name: 1470-nm radial-emitting laser fiber (SiLaC) Description: Thermal ablation of pilonidal sinus tracts using a 1470-nm radial-emitting laser fiber (1470 nm) with power adjusted between 8 and 10 Watt.
Questionnaire and physical examination
Other interventionIntervention Type: Other Intervention Name: Questionnaire and physical examination Description: Postoperative pain evaluation using a visual analog scale (VAS) questionnaire and physical examination.
Tumescent local anesthesia
DrugIntervention Type: Drug Intervention Name: Tumescent local anesthetic solution Description: Tumescent solution prepared with 500 mL normal saline, 20 mL 2% lidocaine, one ampule of epinephrine (1 mg/mL), and 5 mL sodium bicarbonate; infiltrated into the operative field prior to SiLaC.
Treatment groups
Trial outcomes
Primary outcomes
Pain score VAS - Day 1
VAS (visual analog scale for pain) value obtained via questionnaire on day 1 after the operation.The VAS score has a scale of 1-10, where 1 represents completely pain-free and 10 represents the strongest imaginable pain.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.